By CliniEco Medical Team | Updated: August 2026 | Category: Sustainable Medical Supplies
Why Canadian Healthcare Procurement Needs to Understand PLA
Single-use products are foundational to infection prevention in Canadian hospitals, long-term care homes, and clinics. They also generate substantial plastic waste, and procurement managers now carry responsibility for both clinical safety and environmental performance. Polylactic acid (PLA) is the most commercially mature biodegradable polymer used in medical supplies today, and it is appearing in an expanding range of disposable products, from isolation gowns to waste bags. This guide explains what PLA is, how it performs, how it degrades, and what buyers in Canadian healthcare should verify before switching product lines. It draws on peer-reviewed literature, international standards, and Canadian regulation so that purchasing decisions rest on evidence rather than marketing claims.
What Is PLA? Polylactic Acid Defined
Polylactic acid — also written poly(lactic acid) and abbreviated PLA — is a thermoplastic polyester produced from lactic acid, a molecule that can be manufactured by fermenting sugars from crops such as corn, sugarcane, and cassava [1][14]. Unlike conventional polymers such as polyethylene and polypropylene, which are synthesized directly from fossil feedstocks, PLA begins with renewable biomass, which is the basis of most claims about its environmental profile [8].
The Chemistry of PLA
PLA's repeat unit is derived from lactic acid (2-hydroxypropanoic acid), the simplest chiral hydroxy acid. Because each lactic acid molecule contains both a hydroxyl and a carboxyl group, the monomers link through ester bonds into a long polymer chain, giving PLA the structure of an aliphatic polyester [2][3]. Those ester linkages are central to PLA's behaviour: they are susceptible to hydrolysis, which is why the polymer degrades in moist, warm environments, and they influence the material's mechanical response.
PLA Families: PLLA, PDLA, and PDLLA
Lactic acid exists in two mirror-image forms, and the ratio of L- and D-lactide isomers inside the polymer chain determines crystallinity and performance. Poly(L-lactide) (PLLA) is semi-crystalline, stiffer, and slower to degrade; poly(DL-lactide) (PDLLA) is amorphous and degrades faster; and blends of PLLA and PDLA can form a stereocomplex with a higher melting temperature and greater strength [11][12]. Medical device manufacturers select among these grades depending on whether a product must hold load for months or resorb within weeks.
How PLA Is Manufactured
Commercial PLA production follows a two-stage route. First, starch from corn or sugarcane is broken into sugars and fermented by bacteria — typically Lactobacillus strains — into lactic acid [16]. Second, the lactic acid is converted into the cyclic dimer lactide, which is purified and polymerized by ring-opening polymerization (ROP) using a tin-based catalyst [1]. ROP gives manufacturers control over molecular weight and stereochemistry, which is why it dominates industrial production.
Direct polycondensation of lactic acid is possible and cheaper, but it yields lower molecular weights and weaker mechanical properties, so it is reserved for specialized applications [1][14]. Global capacity has expanded steadily: European Bioplastics reported total bioplastics production capacity of about 2.2 million tonnes in 2023, with PLA the single largest segment at roughly 30% of capacity [8]. Grand View Research valued the global PLA market at about USD 1.4 billion in 2023 and projected growth near 15% per year through 2030, driven partly by demand from packaging and medical disposables [9].
Key Physical Properties of PLA
PLA behaves like a conventional rigid thermoplastic at room temperature. Its mechanical performance sits between polystyrene and PET in several respects, which is why it competes with clear packaging plastics and with polypropylene in non-woven applications [2][3].
| Property | Typical value | Note for buyers |
|---|---|---|
| Melting temperature (Tm) | ~175°C | Rules out steam autoclaving |
| Glass transition temperature (Tg) | 55–60°C | Softens below the boiling point of water |
| Tensile strength | 50–70 MPa | Comparable to PET |
| Tensile modulus | 3–4 GPa | Rigid, glassy behaviour |
| Elongation at break | 5–10% | Brittle relative to polypropylene |
| Density | 1.24–1.26 g/cm³ | Higher than PE and PP |
| Optical clarity | Transparent | Suitable for films and packaging |
| Oxygen barrier | Moderate | Weaker than PET at high humidity |
Two numbers matter most for medical supply applications. First, PLA's melting temperature of roughly 175°C means it cannot be autoclaved at 121–134°C and must be sterilized by ethylene oxide, gamma irradiation, or other low-temperature methods [3][13]. Second, its glass transition temperature of approximately 55–60°C means the polymer softens well below the boiling point of water; products must be kept away from hot surfaces and direct heat [2][11].
How PLA Degrades: From Hydrolysis to Compost
PLA does not break down on any fixed timeline. Degradation proceeds in two stages: abiotic hydrolysis first cleaves the ester backbone into shorter chains and lactic acid oligomers, after which microorganisms assimilate the fragments into carbon dioxide, water, and biomass [17][18]. The rate depends on temperature, humidity, and the presence of microbes.
In industrial composting facilities — the environment for which PLA is certified — temperatures of 58°C ± 2°C and sustained moisture accelerate hydrolysis dramatically. Standards such as ASTM D6400 and EN 13432 require at least 90% disintegration within 12 weeks and 90% conversion to CO₂ within 180 days under these conditions [4][5]. Products carrying BPI or Seedling certification marks have been verified against these protocols.
| Environment | Typical conditions | PLA degradation timeline |
|---|---|---|
| Industrial composting | 58°C ± 2°C, aerobic, moist | 90%+ within 180 days (ASTM D6400 / EN 13432) |
| Home composting | Ambient, 20–40°C | Years; generally not certified |
| Soil burial | Ambient, variable moisture | Years |
| Marine environment | 5–25°C, low microbial activity | Years to decades |
| Landfill (anaerobic) | Sealed, oxygen-limited | Very slow; no meaningful degradation |
Outside industrial composting, PLA degrades slowly. Home compost piles rarely reach the required temperature, soil burial takes years, and marine environments are slower still [17][18]. This distinction matters for procurement: a certified-compostable PLA product delivers its environmental benefit only when it reaches an appropriate organics processing stream.
Biocompatibility and Established Medical Uses
PLA has one of the longest clinical track records of any synthetic polymer. Its degradation product, lactic acid, is a normal human metabolite cleared through the tricarboxylic acid cycle, and decades of implantation studies have established that PLLA and its copolymers do not accumulate in tissue [12][13]. Medical-grade PLA is evaluated under the ISO 10993 framework for cytotoxicity, sensitization, irritation, and systemic toxicity before regulatory approval [6].
Absorbable Sutures and Bone Fixation
Absorbable sutures and ligating devices made from lactide-glycolide copolymers (PLGA) have been used in surgery since the 1970s; polyglactin 910 sutures are among the most widely implanted absorbable materials in the world [12][13]. In orthopaedics, PLLA pins, screws, and anchors fix fractures and soft tissue without a second removal surgery, eliminating a common cause of re-operation [11].
Drug Delivery and Tissue Engineering
PLGA microspheres and implants provide controlled, sustained release of therapeutic agents over weeks to months, a technology used in several approved hormone therapies [12]. In regenerative medicine, porous PLLA scaffolds guide bone and cartilage repair, and resorbable membranes support guided tissue regeneration [11].
| Application | Material form | Clinical role |
|---|---|---|
| Absorbable sutures | PLGA monofilament or braided | Wound closure, resorbs within weeks |
| Bone fixation | PLLA pins, screws, anchors | Fracture repair without removal surgery |
| Drug delivery | PLGA microspheres, implants | Controlled release over weeks to months |
| Tissue engineering | Porous PLLA scaffolds | Bone and cartilage regeneration |
| Non-woven disposables | PLA spunbond and melt-blown | Gowns, sheets, caps, wipes |
PLA in Single-Use Medical Supplies
Outside the operating room, PLA non-woven fabrics and films now appear in everyday disposable supplies. Melt-blown and spunbond PLA fibres can be formed into gowns, drapes, sheets, caps, and filtration media, while PLA films serve in bags and packaging [3][11]. For Canadian facilities, the practical question is whether these products meet the performance and compliance expectations of clinical use.
Waste Bags
PLA-based waste bags carry the same day-to-day loads as polyethylene liners in general waste and organics streams. The CliniEco PLA biodegradable waste bags (30-gallon) are designed for healthcare and facility use, with a compostable polymer construction for facilities that route organic waste to industrial composting. For regulated biomedical waste, facilities should continue to use dedicated containers such as the CliniEco red 30-gallon leak-proof biohazard waste bags, which are selected for transport and disposal compliance.
Bed Sheets, Isolation Gowns, and Underpads
Non-woven PLA textiles are soft, breathable, and fluid-resistant in the right constructions. CliniEco offers PLA biodegradable bed sheets (36 x 80 in) for single-patient use, PLA isolation gowns (Level 1) for low-risk procedures, and 5-layer medical underpads with SAP cores for incontinence and examination care. These products are aimed at facilities that want to replace petroleum-derived non-wovens in low-acuity settings without changing clinical workflows [11].
Caps, Masks, and Ancillary Items
Bouffant caps and similar head coverings are among the easiest non-wovens to convert to PLA because mechanical requirements are modest. The CliniEco bouffant caps (24-inch, 100-pack) support daily use in clean and general areas. Facilities typically pilot these items in non-critical zones, measure staff acceptance, and expand once waste-stream logistics are confirmed.
PLA vs. Petroleum Plastics vs. PHA
PLA competes with both fossil-derived polymers and other bioplastics, notably polyhydroxyalkanoates (PHA), which are produced directly by microbial fermentation [18]. Each family has a distinct cost-performance-environment profile.
| Criterion | PLA | Petroleum plastics (PE/PP/PET) | PHA |
|---|---|---|---|
| Feedstock | Renewable (corn, sugarcane) | Fossil fuels | Renewable (microbial fermentation) |
| Relative cost | Low for a bioplastic | Low | High |
| Mechanical behaviour | Rigid, brittle | Flexible to rigid | Flexible to rigid |
| Industrial compostability | Certified (ASTM D6400 / EN 13432) | Not compostable | Certified |
| Marine biodegradation | Slow | Essentially none | Faster |
| Production scale | Million-tonne scale | Very large | Small |
| Heat resistance | Low (Tg 55–60°C) | Moderate to high | Low to moderate |
In practice, PLA wins on cost and availability: it is the least expensive commercially produced biopolyester and the only one manufactured at million-tonne scale [8][9]. PHA offers faster marine biodegradation but at substantially higher cost and lower production volume [18]. For Canadian healthcare buyers, PLA is usually the realistic first step away from fossil-derived disposables; PHA remains a niche option for specialized products.
PLA and Canadian Regulations
Canada's Single-use Plastics Prohibition Regulations (SOR/2022-138), administered by Environment and Climate Change Canada, phase out six categories of single-use plastics: checkout bags, cutlery, food service ware, ring carriers, stir sticks, and straws [10]. The ban targets retail and food-service items; medical devices regulated under the Food and Drugs Act are outside its scope, so clinical products such as gowns, bed sheets, and waste bags are not directly affected [10][15].
Still, the regulatory direction matters to procurement. Provinces and municipalities are expanding organics diversion, and healthcare facilities increasingly face waste-reduction targets. Choosing certified-compostable PLA supplies positions a facility ahead of these pressures. On the quality side, medical devices sold in Canada must meet the Medical Devices Regulations (SOR/98-282), and manufacturers typically maintain ISO 13485 quality management systems to demonstrate traceability and process control [7][15].
Procurement Considerations for PLA Products
Switching to PLA requires more than swapping a SKU. The following factors determine whether a product performs and delivers the promised environmental benefit.
Storage and Shelf Life
PLA is hygroscopic: it absorbs moisture, and hydrolysis accelerates when the polymer is warm and damp. Store PLA products in sealed packaging in a cool, dry area, avoid attics and loading docks exposed to heat, and rotate stock to respect manufacturer shelf-life guidance, typically 12–24 months [3][17]. Degraded polymer shows up as brittleness, cracking, or odour — inspect incoming lots.
Certification Verification
Compostability claims should be verified against standards, not labels. Look for ASTM D6400 or EN 13432 compliance documented with test reports, and third-party marks such as BPI (North America) or Seedling (Europe) [4][5]. Ask the supplier whether certification covers the finished product, including inks, adhesives, and additives, since these can disqualify an item from compostability.
Questions for Suppliers
Request the polymer grade and source, confirm ISO 13485 certification for medical-grade lines, ask for biocompatibility data (ISO 10993) where products contact skin, and confirm sterilization compatibility with your facility's method [6][7]. A responsible supplier will share these documents without resistance.
Conclusion
PLA is a renewable, compostable polyester with a mature supply chain, a long clinical history, and practical applications across single-use medical supplies. It is not a universal substitute: it softens at moderate temperatures, cannot be autoclaved, and only delivers its environmental value when routed to industrial composting. For Canadian healthcare procurement teams, the defensible strategy is to verify standards and certifications, pilot PLA products in appropriate settings, and build the waste-stream partnerships that make compostable claims real. CliniEco's PLA product line — waste bags, bed sheets, isolation gowns, underpads, and caps — offers a starting point for facilities ready to evaluate these materials against their own clinical and sustainability requirements. Visit CliniEco to review the full range.
Related reading
Frequently Asked Questions
Is PLA safe for use in medical settings?
Yes, when the product is manufactured to medical standards. PLA's degradation product, lactic acid, is a normal human metabolite, and medical-grade PLA devices are evaluated under ISO 10993 for biocompatibility [6][13]. For disposable supplies, confirm that the specific product has documented biocompatibility and quality data from the manufacturer.
Does PLA actually biodegrade?
Under industrial composting conditions (58°C, sustained moisture, active microbes), PLA meets ASTM D6400 and EN 13432 thresholds — at least 90% disintegration within 12 weeks and 90% biodegradation within 180 days [4][5]. In soil, home compost, or the ocean, degradation takes years, so disposal routing determines the outcome.
Can PLA products be sterilized like polypropylene?
No. PLA's melting point near 175°C and glass transition near 55–60°C rule out steam autoclaving. Ethylene oxide, gamma irradiation, and other low-temperature methods are used instead [3][13]. Confirm the sterilization method with the supplier before purchase.
What is the difference between PLA and PHA?
PLA is polymerized from fermented lactic acid and is cheaper and more widely produced; PHA is synthesized inside microorganisms and biodegrades faster in marine environments but costs considerably more [18]. PLA is the practical choice for most medical disposables today.
Are PLA medical supplies covered by Canada's single-use plastics ban?
The Single-use Plastics Prohibition Regulations cover retail and food-service items such as checkout bags, cutlery, and straws, and they do not apply to medical devices regulated under the Food and Drugs Act [10][15]. Clinical products such as gowns, sheets, and waste bags are outside the ban, though facilities still pursue them for waste-reduction goals.
Related reading: explore our eco-friendly and sustainable product guides.
understand PHA vs PLA in our bioplastics pillar guide.
References
- Taib, N. A. A. B., Rahman, M. R., Huda, D., et al. "A Review on Poly Lactic Acid (PLA) as a Biodegradable Polymer." Polymers (MDPI), 15(5), 1195. 2023.
- Farah, S., Anderson, D. G., Langer, R. "Physical and mechanical properties of PLA, PLGA, and their copolymers." Advanced Drug Delivery Reviews (ScienceDirect), 107, 367–392. 2016.
- Hamad, K., Kaseem, M., Yang, H. W., Deri, F., Ko, Y. G. "Properties and medical applications of poly lactic acid: A review." Express Polymer Letters, 9(5), 435–455. 2015.
- ASTM International. "ASTM D6400-23: Standard Specification for Labeling of Plastics Designed to be Aerobically Composted in Municipal or Industrial Facilities." ASTM International, West Conshohocken, PA. 2023.
- European Committee for Standardization (CEN). "EN 13432:2000 — Packaging: Requirements for packaging recoverable through composting and biodegradation." CEN, Brussels. 2000.
- International Organization for Standardization. "ISO 10993-1:2018 — Biological evaluation of medical devices — Part 1: Evaluation and testing within a risk management process." ISO, Geneva. 2018.
- International Organization for Standardization. "ISO 13485:2016 — Medical devices — Quality management systems — Requirements for regulatory purposes." ISO, Geneva. 2016.
- European Bioplastics. "Bioplastics market development update." European Bioplastics e.V., Berlin. 2025.
- Grand View Research. "Polylactic Acid Market Size, Share & Trends Analysis Report, 2024–2030." Grand View Research, San Francisco. 2024.
- Environment and Climate Change Canada. "Single-use Plastics Prohibition Regulations (SOR/2022-138)." Government of Canada, Ottawa. 2022.
- Capuana, E., Lopresti, F., Ceraulo, M., La Carrubba, V. "Poly(Lactic Acid) for Biomedical Applications: A Review." Polymers (MDPI), 14(21), 4713. 2022.
- Tyler, B., Gullotti, D., Mangraviti, A., Utsuki, T., Brem, H. "Polylactic acid (PLA) controlled delivery carriers for biomedical applications." Advanced Drug Delivery Reviews (ScienceDirect), 107, 163–175. 2016.
- Athanasiou, K. A., Niederauer, G. G., Agrawal, C. M. "Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers." Biomaterials (PubMed/PMC), 17(2), 93–102. 1996.
- Garlotta, D. "A Literature Review of Poly(Lactic Acid)." Journal of Polymers and the Environment (Springer), 9(2), 63–84. 2001.
- Health Canada. "Medical Devices Regulations (SOR/98-282)." Government of Canada, Ottawa. 1998 (consolidated 2025).
- Nampoothiri, K. M., Nair, N. R., John, R. P. "An overview of the recent developments in polylactide (PLA) research." Bioresource Technology (ScienceDirect), 101(22), 8493–8501. 2010.
- Zaaba, N. F., Jaafar, M. "A review on degradation mechanisms of polylactic acid (PLA)." Polymer Bulletin (Springer), 77, 1679–1703. 2020.
- European Bioplastics. "Bioplastics facts and figures." European Bioplastics e.V., Berlin. 2023.
Related Reading
Explore more guides in this category:
0 comments